Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.72 USD | +0.03% | +1.70% | -11.72% |
May. 09 | UBS Adjusts Price Target on Premier to $21 From $22, Maintains Neutral Rating | MT |
May. 08 | Baird Adjusts Price Target on Premier to $22 From $25, Keeps Neutral Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.72% | 2.07B | |
-5.94% | 182B | |
+1.88% | 111B | |
-3.48% | 68.48B | |
+0.18% | 49.69B | |
+7.78% | 44.46B | |
+2.33% | 40.67B | |
+22.34% | 31.22B | |
+1.79% | 26.09B | |
+15.30% | 25.32B |
- Stock Market
- Equities
- PINC Stock
- News Premier, Inc.
- Transcript : Premier, Inc. Presents at Barclays Global Healthcare Conference 2022, Mar-15-2022 10